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INTRODUCTION
Children presenting with cough and other 
symptoms of respiratory tract infection 
(RTI) are the most frequent attenders 
to general practice internationally, are 
almost all managed in primary care, and 
the majority still receive antibiotics.1–3 A 
very small percentage of children are 
hospitalised for serious bacterial illnesses 
or complications.4,5 However, GPs are risk 
averse and report prescribing antibiotics 
at the point of presentation to this patient 
group ‘just in case’6,7 and in fear of a poor 
outcome.6–9
This uncertainty is fuelled by the very 
limited experimental or observational 
evidence available regarding the impact of 
different antibiotic prescribing strategies on 
major adverse outcomes among children. 
Available systematic reviews suggest that 
antibiotics have limited efficacy in treating 
a large proportion of upper RTIs10–13 but 
the reviews are underpowered to assess 
complications and there is little evidence 
for bronchitis, in particular. Although there 
is some evidence for adults,14–19 there is 
almost no meaningful evidence in children 
regarding complications if antibiotics are 
withheld for respiratory infections. The 
major problem with continuing to prescribe 
for respiratory infections in children is that 
primary care antibiotic use is a major driver 
of antibiotic resistance internationally.20 
Two large prospective cohort studies of 
adults with RTI symptoms demonstrated 
that either immediate or delayed 
antibiotic prescriptions can modify health 
outcomes.18,19 The authors were aware of 
no comparable data in children. This paper 
used data from a large cohort study to 
establish whether an immediate or delayed 
antibiotic prescription given to children 
with acute cough and RTI in primary care 
modifies risk of subsequent hospitalisation 
or reconsultation with deterioration.
METHOD
A large, four-centre (England, UK) 
prospective cohort study was conducted 
that recruited children aged 3 months to 
<16 years presenting to primary care with 
acute cough and RTI between July 2011 
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Background
Clinicians commonly prescribe antibiotics to 
prevent major adverse outcomes in children 
presenting in primary care with cough and 
respiratory symptoms, despite limited meaningful 
evidence of impact on these outcomes.
Aim
To estimate the effect of children’s antibiotic 
prescribing on adverse outcomes within 30 days 
of initial consultation.
Design and setting
Secondary analysis of 8320 children in a 
multicentre prospective cohort study, aged 
3 months to <16 years, presenting in primary 
care across England with acute cough and other 
respiratory symptoms.
Method
Baseline clinical characteristics and antibiotic 
prescribing data were collected, and generalised 
linear models were used to estimate the effect 
of antibiotic prescribing on adverse outcomes 
within 30 days (subsequent hospitalisations and 
reconsultation for deterioration), controlling for 
clustering and clinicians’ propensity to prescribe 
antibiotics.
Results
Sixty-five (0.8%) children were hospitalised and 
350 (4%) reconsulted for deterioration. Clinicians 
prescribed immediate and delayed antibiotics to 
2313 (28%) and 771 (9%), respectively. Compared 
with no antibiotics, there was no clear evidence 
that antibiotics reduced hospitalisations 
(immediate antibiotic risk ratio [RR] 0.83, 95% 
confidence interval [CI] = 0.47 to 1.45; delayed 
RR 0.70, 95% CI = 0.26 to 1.90, overall P = 0.44). 
There was evidence that delayed (rather than 
immediate) antibiotics reduced reconsultations 
for deterioration (immediate RR 0.82, 95% 
CI = 0.65 to 1.07; delayed RR 0.55, 95% CI = 0.34 
to 0.88, overall P = 0.024).
Conclusion
Most children presenting with acute cough and 
respiratory symptoms in primary care are not at 
risk of hospitalisation, and antibiotics may not 
reduce the risk. If an antibiotic is considered, a 
delayed antibiotic prescription may be preferable 
as it is likely to reduce reconsultation for 
deterioration.
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and May 2013. The results from the primary 
aim of the study have been published.5 Here 
are presented findings from a secondary 
analysis.
The protocol has been described 
elsewhere.21 In summary, eligible children 
presenting to primary care were recruited by 
prescribing ‘clinicians’ (GPs and prescribing 
practice nurses) across four centres if they 
presented with acute cough as the most 
prominent symptom, combined with other 
symptoms or signs suggestive of RTI. 
Clinicians who self-reported prescribing 
antibiotics in ≤30% to children with RTIs 
were invited to participate. Following 
informed consent, clinicians completed a 
structured case report form (Appendix 1) 
that included sociodemographics, parent-
reported symptoms, clinician-assessed 
signs, diagnosis, and whether an immediate 
or delayed antibiotic was prescribed 
(including number of days delayed) at the 
time of the consultation.
The main outcomes, hospitalisation for 
any RTI in the 30 days following recruitment 
and reconsultation for deterioration (a 
proxy marker for reconsultation for the 
same episode of RTI illness with evidence 
of worsening illness, shown to be reliably 
assessed),22 were collected via a detailed 
review of the child’s medical record. History 
of chronic conditions was also recorded. 
Medical record reviews were generally 
conducted 3 months post-recruitment for 
each child, to allow for adequate feedback to 
occur. On some occasions this was slightly 
longer than 3 months, and in all cases the 
period of time was sufficient to allow both 
reconsultations and complications to occur. 
Double, independent medical record review 
was undertaken in a random set of 1% 
of participants to estimate inter-reviewer 
error.
Data preparation
Children referred for acute hospitalisation 
at the consultation were excluded from the 
analysis, as clinicians’ prescribing behaviour 
was expected to differ for children whom 
they had decided to refer to hospital on the 
same day as the consultation, compared 
with those they did not.
Common clinical cut-offs were used 
for continuous data where possible (high 
temperature >37.8°C)23 and were age-
related if appropriate (age-specific heart 
and respiratory rates and blood pressure).24 
UK guidelines for low oxygen saturation 
level (≤95%) were used.25 Given the large 
number of variables, continuous variables 
were dichotomised using 25th or 75th 
percentile cut-offs as appropriate. For 
carer-reported symptom severity (mild, 
moderate, or severe) in the 24 hours 
prior to consultation, dichotomy for each 
variable was split, depending on the overall 
prevalence, to either ‘severe’ if more than 5% 
of the whole cohort fell into this category or 
‘moderate and severe’ if the proportion was 
smaller. This pragmatic cut-off was chosen 
prior to analysis to avoid variables with very 
low prevalence. Capillary refill time (CRT) 
was coded as normal (≤2 seconds) or long 
(≥3 seconds).26,27 Multiple deprivation score 
was based on the family postcode using the 
UK Indices of Multiple Deprivation 2007.28
Covariates
Variables measured at the baseline 
consultation (symptoms, signs, 
demographics) were identified as possible 
confounders/covariates. These variables 
were considered during the analysis of 
secondary outcomes (Appendix 2).
Statistical analysis
All data were analysed using STATA 
(version 13.1). The κ statistic to assess 
inter-rater reliability of the two main 
outcomes was calculated. Generalised 
linear modelling with a log link to produce 
risk ratios (RR) was used, accounting for 
clustering by clinician and controlling for 
potential covariates associated with the 
prescription strategy and the two outcomes. 
Two models were generated: in the first, 
variables were selected using backward 
stepwise selection with variables retained 
if the P-value <0.05. In the second model, 
analyses were conducted post-hoc, where 
a stratified propensity score was created, 
which allowed for more rigorous control of 
potential confounding by indication.29,30
How this fits in
Antibiotic prescribing to children in primary 
care is one of the key areas of inappropriate 
prescribing. This is mainly due to the 
lack of evidence for, and uncertainty 
regarding, which children are at risk of 
poor outcome. This study investigated 
whether antibiotic prescribing had an 
impact on two adverse health outcomes 
for children: hospitalisation for respiratory 
tract infections and reconsultation for 
deteriorating symptoms. The study shows 
that there is little evidence to justify the use 
of antibiotics for reducing hospitalisation, 
which occurred very rarely, and supports 
previous research in adults that a delayed 
antibiotic prescribing strategy is likely to 
reduce reconsultation for deterioration.
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RESULTS
Ascertainment and baseline 
characteristics
Between July 2011 and May 2013, 518 
clinicians recruited children from 247 
primary care practices across England. A 
total of 8613 children were recruited, and, 
of these, 219 (3%) children were excluded: 
181 did not meet eligibility, 32 children did 
not have baseline data, and six children 
were withdrawn. Seventy-four children 
referred for acute hospital admission on 
the day of recruitment were excluded 
from the analysis, leaving a total of 8320 
children. Antibiotic prescription data from 
the baseline consultation were available 
for 100% of these children and all analyses 
used this final sample of 8320. Figure 1 
details the flow of participants through 
the study. The outcome of hospitalisation 
was obtained for 8320 (100%) children, 
and reconsultation for deterioration was 
obtained for 98% (n = 8136/8320).
Inter-reviewer agreement analysis 
for medical record data collection was 
assessed. For hospitalisation this was 
90% (κ 0.80) and 84% for reconsultation 
within r the same episode of illness (κ 0.67). 
Missing data for candidate predictors were 
infrequent (<2%) with the exception of 
oxygen saturation (50% missing values) due 
to lack of available paediatric monitors.
Clinicians prescribed antibiotics for 
3084/8320 children (37%), with 2313 (28%) 
children prescribed immediate and 771 (9%) 
delayed antibiotics. The range of days the 
prescription was delayed for was between 
0–10, median 2 (interquartile range [IQR] 
2–3).
Of the 8320 children included in the 
analysis, 65 (0.8%) were hospitalised for an 
RTI in the 30 days following recruitment. 
Median time to hospitalisation was 4 days 
(IQR 1–15) with 5% hospitalised on the day 
of recruitment (day 0), 52% on days 1–7, 
17% on days 8–14, and 26% on days 15–30. 
Of the 65 children hospitalised, 25 (38.5%) 
had been prescribed an antibiotic. 
The most common RTI discharge 
diagnoses (Table 1) were bronchiolitis 
(20%), lower RTI (14%), and upper RTI 
(12%); other diagnoses included viral 
wheeze, exacerbation of asthma, tonsillitis, 
croup, unspecified viral illness, chest 
infection, bronchiolitis and bronchitis, 
viral pneumonitis, pyrexia, and febrile 
convulsions.
Just over one-fifth (22.5%; 1830/8136) of 
children reconsulted for any RTI symptoms 
in the 30 days after consultation, 14% 
(1163/8136) reconsulted for the same 
episode of RTI illness, and 4% (350/8136) 
reconsulted for the same RTI with evidence 
in their medical records of deteriorating 
symptoms.
Appendix 3 shows the clinical history, 
sociodemographics, parent/carer-reported 
symptoms, clinical signs observed by the 
clinician, and adverse health outcomes 
(in the 30 days post-baseline) for the 
children with different antibiotic strategies 
at the baseline consultation. There is 
wide variation in the number of children 
prescribed an immediate, delayed, or no 
antibiotic with regard to parent-reported 
symptoms and clinical signs.
Invited to participate 
(n = 9043)
Started recruitment 
process  (n = 8879)
Consented (n = 8613)
Full dataset available
(n = 8394)
Not invited to participate (n = 224)
Clinician too busy to use agreed recruitment strategy (n = 85); child 
not unwell enough (n = 24); child too unwell (n = 9); clinician forgot to 
ask (n = 5); miscellaneous including: already recruited, other child in 
the study, uncooperative patient/carer/child, child anxious/upset, 
did not attend with a carer, language barrier, clinician did not recruit 
the child fully, child meets exclusion criteria or not eligible patients, 
computer too slow, child already on antibiotics, learning disabilities, 
run out of recruitment packs (n = 101)
Invitation declined (n = 164)
Parent/carer thought study would take too much time (n = 54); 
miscellaneous reasons including: perceived difficulties with 
completing symptom diary, language barriers, another child already 
recruited, person attending with child was not carer, concerns about 
access to medical records, child had complex needs (n = 45); no 
reason given (n = 41); parent not interested (n = 22); parent thought 
child too ill (n =  2)
Consent form not 
received or not valid 
(n = 266)
Excluded by research team (n = 213)
Child previously entered study (n = 77); immunocompromised  
(n = 34); child out of age range (n = 34); no baseline data (n = 32); 
illness duration >28 days (n = 31); temporary resident at practice 
(n = 3); routine swab taken (n = 1); child’s date of birth not
validated (n = 1)
Withdrawn by parent (n = 6)
No reason (n = 3); demographic data collected too intrusive (n = 1); 
parent/carer did not like study having identifiable information 
about child (n = 1); family moved house (n = 1)
Withdrawn from analysis (n = 74)
Referred for acute admission on the day of recruitment (74)
Available for analysis
(n = 8320) (99% of full 
dataset)
Figure 1. Flow of participants through the 
study. 
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Relationships between baseline 
characteristics and health outcomes
Hospitalisation. Table 1 shows the 
discharge diagnoses for the hospitalised 
children and whether they received an 
antibiotic or not. There was no evidence of 
a difference between hospital diagnoses in 
children prescribed an antibiotic compared 
with those who were not (χ2 test: P = 0.46). 
Table 2 details the univariable 
and multivariable relationships 
between antibiotic prescribing at the 
baseline consultation and subsequent 
hospitalisation. There was no clear evidence 
at the univariable level or multivariable 
level that prescribing immediate or delayed 
antibiotics reduced the risk of a child 
being hospitalised in the 30 days post-
baseline consultation (immediate RR 0.83, 
95% confidence interval [CI] = 0.47 to 1.45; 
delayed RR 0.70, 95% CI = 0.26 to 1.90, 
overall P = 0.44).
Reconsultation within 30 days for 
deterioration. Table 3 describes the 
univariable and multivariable relationships 
between prescription at the baseline 
consultation and reconsultation for 
deterioration. Both univariable and 
multivariable analysis, accounting for 
clinician clustering, indicate there is 
evidence to suggest a difference in those 
reconsulting with deteriorating symptoms 
in the subsequent 30 days, for those 
prescribed an antibiotic compared with 
those who were not (immediate odds ratio 
[OR] 0.82, CI = 0.65 to 1.07; delayed OR 0.55, 
CI = 0.34 to 0.88, overall P = 0.02). Delayed 
antibiotics reduced reconsultation with 
deterioration by almost half and, although 
the point estimate for those prescribed 
immediate antibiotics suggests a reduction, 
the 95% CI means the absence of an effect 
cannot be ruled out.
DISCUSSION
Summary
This is the first cohort evidence available to 
date to indicate that prescribing immediate 
or delayed antibiotics in children does not 
prevent RTI-related hospitalisation in the 
30 days post primary care consultation. 
Hospital admissions in the 30 days after the 
baseline consultation were rare and almost 
none of the reasons for admission were 
related to the withholding of antibiotics. This 
has demonstrated that delayed antibiotics 
reduced the risk of the child reconsulting 
for the same illness with deterioration. For 
those given immediate antibiotics, the trend 
was in the same direction, although no clear 
Table 1. Hospital discharge diagnoses in the 30 days post-recruitment 
for children who were and were not prescribed an antibiotic at the 
baseline general practice consultation 
 Number of children
Hospital diagnosis Immediate Delayed Not prescribed Total
Bronchiolitis 1 2 10 13
LRTI 6 0 3 9
URTI 0 3 5 8
Exacerbation of asthma 2 0 4 6
Tonsillitis 3 0 3 6
Viral wheeze 2 0 4 6
Croup 1 1 3 5
Unspecified viral illness 1 0 2 3
Chest infection 1 0 1 2
Bronchiolitis and bronchitis 0 0 1 1
LRTI/viral pneumonitis 1 0 0 1
Pyrexia 1 0 0 1
URTI and febrile convulsions 0 0 1 1
No record 0 0 3 3
Total 19 6 40 65
LRTI = lower respiratory tract infection. URTI = upper respiratory tract infection.
Table 2. Association between children’s antibiotic prescription strategies and hospitalisation in the 30 days 
following the baseline consultation
    Multivariable analysis Analysis stratified by 
    accounting for covariates propensity score 
 Not  Univariable analysis where P<0.05 and and accounting  
 hospitalised Hospitalised clustering by clinician clustering by clinician for clustering by clinician
 n % n % RR 95% CI P-valuea RR 95% CI P-valuea RR 95% CI P-valuea
No antibiotic 5196/8255 62.9 40/65 61.5 Ref Ref 0.53 (2 df) Ref Ref 0.31 (2 df)b Ref Ref 0.44 (2 df)
Immediate 2292/8255 27.8 21/65 32.3 1.19 0. 70 to 1.88  0.81 0.40 to 1.32  0.83 0.47 to 1.45
Delayed 767/8255 9.3 4/65 6.2 0.68 0.24 to 1.88  0.62 0.22 to 1.66  0.70 0.26 to 1.90
aOverall P-value. bCovariates included (<0.05): age (<2 years), current asthma, short (<3 days) illness duration prior to baseline, moderate/severe vomiting in the 24 hours before 
baseline, clinician-reported wheeze, high temperature (age-related cut-offs). df = degrees of freedom. Ref = reference. RR = risk ratio.
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evidence was found; it is not clear if this 
is due to a lack of power or a true finding. 
This supports previous research in adults 
that also suggests delayed prescribing 
should be considered if an antibiotic is being 
prescribed.
Strengths and limitations
The study’s large observational 
dataset reflects a realistic primary care 
setting and the findings are likely to be 
generalisable to general practice in other 
high-income countries. Follow-up and 
case ascertainment were high. The study 
has several potential limitations. First, 
prescribing rates were relatively low in this 
cohort, particularly delayed prescribing, 
which may impact on the generalisability. 
The low prescribing rates are likely to be 
because clinicians who self-classified 
themselves as ‘low prescribers’ were 
eligible to recruit to the study. Second, 
establishing whether prescribed antibiotics 
were dispensed and consumed was not 
possible, although previous studies suggest 
that immediate prescriptions commonly 
are consumed.31 Third, both health 
outcomes were rare and event rates low 
(as expected), particularly hospitalisation, 
which unavoidably limits analytic power. 
Fourth, as with any secondary analysis of 
observational data there may be residual 
confounding, although only a few variables 
predicted hospitalisation, which lessens 
any effect of confounding by indication. For 
reconsulting for deterioration, very little 
change in risk ratios were recorded when 
a wide range of potential covariates were 
included in the model, which suggests that 
confounding, for those variables that were 
recorded, was not a major issue.
Comparison with existing literature
The authors did not find evidence to 
support the use of an immediate antibiotic 
prescription as a means of clearly reducing 
hospitalisations for RTIs. Even if the lower 
confidence intervals for the estimate are 
taken, more than 200 children would need 
to be given an immediate antibiotic for 
one hospitalisation to be prevented. These 
findings are in agreement with evidence 
from systematic reviews11–13,32 where little 
or no evidence was found to support their 
use in children or adults. The authors found 
similar estimates for reconsultations for 
deterioration with that of one large cohort 
study investigating new or non-resolving 
symptoms in adult sore throat.18,19 Similarly, 
this evidence supports the idea that a 
delayed antibiotic script is not necessarily 
equivalent to a ‘no prescription’ strategy 
and can be a useful means to reduce 
reconsultations18,19,33,34 as well as the use of 
antibiotics.31,33–36 Evidence from this cohort 
demonstrated which symptoms and signs 
predict complications in children presenting 
to general practice with acute cough and 
RTI.5 This may reduce uncertainty around 
distinguishing which children might benefit 
from antibiotics, from those who are at a 
much lower risk of poor health outcomes 
where the clinician can safely make a 
‘no prescription’ decision.21 However, a 
multifaceted approach and more complex 
behavioural interventions may be required 
to support clinicians to reduce their 
prescribing to children.37–39
Qualitative evidence suggests that the 
relationship between parents and clinicians, 
in relation to antibiotic prescribing for their 
child’s RTI, is complex. Studies show that 
clinicians are prescribing ‘just in case’,6 
feel uncertain about prognostic outcomes,7 
and perceive pressure from parents to 
prescribe when parents want symptomatic 
relief and safety-netting advice.40,41 The 
authors’ evidence indicates a delayed 
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prescription reduces the likelihood of a 
parent reconsulting with their child with 
deterioration. The reasons for this are not 
entirely clear, but may represent the timely 
access to antibiotics if illness is not settling, 
or prompt treatment of a secondary 
bacterial infection following an initial viral 
infection.
Implications for practice 
These findings suggest that there is little 
evidence that antibiotics substantially 
reduce the risk of hospitalisation in children 
presenting to primary care; and that these 
risks are extremely low for the majority of 
children presenting with acute cough and 
RTI. The rates of prescribing in this cohort, 
even for self-classified ‘low prescribers’, 
indicate continued need for interventions 
and strategies to better target antibiotics. 
These results provide reassurance that, 
when faced with a child and uncertain 
prognosis, delayed prescribing can be a 
safe and effective method to reduce the 
child’s probability of reconsulting with 
deterioration and can act as part of safety-
netting strategies for parents.
The implications for clinical practice are 
that the majority of children presenting with 
acute cough and respiratory symptoms in 
primary care are not at risk of hospitalisation, 
and antibiotics may not reduce the risk. 
If clinicians are considering an antibiotic, 
a delayed prescription may be preferable 
as it is likely to reduce reconsultation for 
deterioration.
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Symptoms present
During illness? Last 24 hours? Severity in last 24 hours (tick one)
CASE REPORT FORM
ID Background informatIon
DOB
Female0
Today’s date
Informed consent for
study obtained
How unwell does the parent
consider the child to be?
Carer reported Symptoms
Clinician examination and management
D D / /M M Y Y Y Y
D D / /M M 2 0 Y Y
Male1 PTO for codes, if other
ethnicity, please describe below
Gender
No0
No0 Yes1 If yes Mild1 Moderate2 Severe3
Yes1
Well Very unwell
0 1 2 3 4 5 6 7 8 9 10
Don’t
know88
Does the
mother smoke?
No0 Yes1Has illness got a lotworse recently?
No0 Yes1 Don’t
know88
1
Mother still breast
feeding child at
three months?
Ethnicity
Mother’s
age
Duration of
illness days
If Yes, how many days ago
did it start to get worse? days
# children in home
(inc. unwell child)
How unwell do you consider the child to be?
Very unwellWell
0 1 2 3 4 5 6 7 8 9 10
No0 Yes1 If yes
Dry cough
Productive/wet cough
Absent0 Present1
Pallor
Grunting
Nasal flaring
Absent0 Unilateral1 Bilateral2
Wheeze
Crackles/crepitations
Bronchial breathing
Stridor
Inter/subcostal recession
Inflamed pharynx/tonsils
Banking/croupy cough
Blocked or runny nose
Change in cry
Breathing faster than normal (shortness of breath)
Wheeze or whistling in the chest
Fever
Chills/shivering
Diarrhoea
Vomiting (including after cough)
Taking fewer fluids/ milk feeds
Chest/shoulder pain
Headache
Muscle aches all over
Confusion/disorientation
Eating less
Low energy/fatigue/lethargy
Disturbed sleep
Passing urine less often/dryer nappies
Please tick NA if the child is too young/uncommunicative for the parent to know the following > NA
1
Temperature °C. Pulse bpm
Respiratory rate bpm Pulse bpm
Main working respiratory tract diagnosis
Consciousness level Normal0 irritable1
Capillary refill time two seconds or less0 three seconds or more1
drowsy2
No0 Yes1My gut feeling is ‘something is wrong’
No0 Yes1Referral for acute admission today?
2011 04 08 TARGET CRF LOS centre version 1.0
No0 Yes1 immediate1 Yes1 delayed2 byAntibiotics prescribed? days
Appendix 1. Case report form used to record baseline data for the prospective TARGET cohort study (a similar online version was also used).
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Appendix 2. Potential covariates associated with hospitalisation and reconsultation in the 30 days following 
baseline
Characteristic  Data source
Sociodemographic variables
Age  <2 years versus ≥2 years Parent
Sex  Male versus female Parent
Age of mother at child’s birth ≤26 years versus >26 years Parent
Breastfed for ≥3 months Yes versus no Parent
Mother smokes Yes versus no Parent
Children in the home ≥2 versus <2 Parent
IMD score  High, top quintile versus quintiles 1 to 4 Parent
Ethnicity White versus mixed, Asian or Asian British,  Parent 
 black or black British, Chinese, or other ethnic groups
Past medical history
Consultations for RTI in the 12 months prior to baseline  ≥2 versus <2 General practice medical notes
Asthma (current diagnosis) Yes versus No General practice medical notes
Chronic conditions (any) Yes versus No General practice medical notes
Asthma (previous diagnosis) Yes versus No General practice medical notes
Parent-reported symptoms (present during the illness)
Illness duration prior to baseline (days) <3 versus ≥3 Parent
Breathing faster than normal Present versus absent Parent
High parent illness severity score  ≥7 versus <7 Parent
Low energy/fatigue/lethargy Present versus absent Parent
Fever Present versus absent Parent
Eating less Present versus absent Parent
Illness much worse recently Yes versus no Parent
Disturbed sleep Present versus absent Parent
Wheezing or whistling in the chest Present versus absent Parent
Chills/shivering Present versus absent Parent
Taken fewer fluids/milk feeds Present versus absent Parent
Productive wet cough Present versus absent Parent
Vomiting (including after a cough) Present versus absent Parent
Passing urine less often/drier nappies Present versus absent Parent
Change in cry Present versus absent Parent
Dry cough Present versus absent Parent
Diarrhoea Present versus absent Parent
Barking/croupy cough Present versus absent Parent
Blocked/runny nose Present versus absent Parent
Parent-reported symptoms (last 24 hours)
Change in cry (moderate/severe) Present versus absent Parent
Vomiting (moderate/severe) Present versus absent Parent
Disturbed sleep (severe) Present versus absent Parent
Taking fewer fluids/milk feeds (moderate/severe) Present versus absent Parent
Passing urine less often/drier nappies (moderate/severe) Present versus absent Parent
Productive wet cough (severe) Present versus absent Parent
Chills/shivering (moderate/severe) Present versus absent Parent
Eating less (severe) Present versus absent Parent
Low energy/fatigue/lethargy (moderate/severe) Present versus absent Parent
Wheeze (moderate/severe) Present versus absent Parent
… continued 
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Appendix 2 continued. Potential covariates associated with hospitalisation and reconsultation in the 30 days 
following baseline
Fever (severe) Present versus absent Parent
Breathing faster than normal (moderate/severe) Present versus absent Parent
Blocked/runny nose (severe) Present versus absent Parent
Dry cough (severe) Present versus absent Parent
Barking/croupy cough (moderate/severe) Present versus absent Parent
Diarrhoea (moderate/severe) Present versus absent Parent
Clinical signs
Inter/subcostal recession Present versus absent Clinician
Bronchial breathing (unilateral/bilateral) Present versus absent Clinician
Nasal flaring Present versus absent Clinician
Pallor Present versus absent Clinician
Wheeze (unilateral/bilateral) Present versus absent Clinician
Abnormal consciousness Yes versus no Clinician
High temperature  ≥37.8°C versus <37.8°C Clinician
High respiratory rate (age-related cut-offs) Present versus absent Clinician
High pulse (age-related cut-offs) Present versus absent Clinician
Inflamed pharynx Present versus absent Clinician
Grunting Present versus absent Clinician
Crackles/crepitations (unilateral/bilateral) Present versus absent Clinician
Slow capillary refill time  ≥3 seconds versus ≤2 seconds Clinician
Stridor Present versus absent Clinician
High clinician illness severity score ≥4 versus <4 Clinician
Clinician gut feeling that ‘something is wrong’ Yes versus no Clinician
IMD =  Index of Multiple Deprivation. RTI =  respiratory tract infection.
British Journal of General Practice, October 2018  e691
Appendix 3. Characteristics of the children and antibiotic prescribing strategies at the baseline general 
practice consultation
 No antibiotic Immediate antibiotics Delayed antibiotics
 n/N % n/N % n/N %
Clinical history
RTI consultations in the 12 months prior  to baseline (≥2 consultations) 1739/5106 34 839/2269 37 262/766 34
Any chronic conditiona 916/5235 18 492/2311 21 157/771 20
Current asthma diagnosisb 415/5236 8 247/2313 11 77/771 10
Previous asthma diagnosis 184/5235 4 124/2313 5 41/771 5
Sociodemographics
Sex (male) 2693/5236 51 1230/2313 53 365/771 47
Age (<2 years) 1875/5236 36 715/2313 31 212/771 28
Children in the home (>1) 3292/5213 63 1644/2303 71 526/765 69
Breastfeeding (at 3 months)  2132/4887 44 934/2117 44 350/718 49
Ethnicity (white) 4015/5212 77 1889/2298 82 585/766 76
Mother smokes  914/5178 18 447/2277 20 115/759 15
Young mother 1566/5222 30 652/2304 28 197/768 26
IMD quintile (most deprived) 1066/5236 20 436/2313 19 117/771 15
Parent-reported symptoms present at any time during the illness
High severity score (parent: ≥7/10) 993/5218 19 914/2305 40 209/771 27
Short duration of illness (≤ 3 days) 1598/5233 31 533/2312 23 234/771 30
Illness worsened recently 3114/5230 60 1835/2310 79 527/770 68
Dry cough 3326/5234 64 1205/2309 52 447/771 58
Productive wet cough 2556/5230 49 1455/2310 63 440/770 57
Barking/croupy cough 1357/5232 26 605/2307 26 161/771 21
Blocked/runny nose 4202/5234 80 1833/2311 79 620/770 81
Change in cry 850/5221 16 385/2302 17 131/766 17
Breathing quicklyc 1602/5235 31 1057/2311 46 279/771 36
Wheezing/whistling in chest 1885/5232 36 1058/2311 46 303/771 39
Chills 948/5233 18 679/2310 29 212/770 28
Fever 2865/5234 55 1733/2311 75 533/771 69
Diarrhoea 783/5233 15 340/2311 15 101/771 13
Vomitingd 1349/5234 26 765/2311 33 201/771 26
Eating less than normal 2855/5232 55 1627/2310 70 498/771 65
Fewer fluids 1529/5232 29 834/2309 36 253/771 33
Low energy 2512/5234 48 1475/2310 64 483/771 63
Disturbed sleep 3880/5234 74 1926/2311 83 592/770 77
Less urine than normal 652/5223 13 348/2307 15 131/770 17
Parent-reported symptoms present in the last 24 hours (severe)      
Dry cough 337/5215 6 174/2306 8 40/768 5
Productive wet cough 329/5215 6 270/2304 12 68/770 9
Blocked/runny nose 406/5202 8 201/2304 9 52/765 7
Fever 228/5217 4 236/2302 10 70/768 9
Eating less 208/5213 4 175/2299 8 38/769 5
Disturbed sleep 784/5208 15 430/2305 19 116/765 15
Parent-reported symptoms present in the last 24 hours (moderate or severe)
Barking cough 957/5226 18 446/2303 19 111/771 14
Change in cry 480/5212 9 224/2301 10 73/765 10
Chills/shivering 382/5229 7 362/2305 16 84/769 11
Breathing quicklyc 836/5224 16 619/2308 27 146/771 19
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Appendix 3 continued. Characteristics of the children and antibiotic prescribing strategies at the baseline 
general practice consultation
Wheeze 878/5225 17 585/2305 25 128/771 17
Diarrhoea 216/5229 4 103/2309 5 22/771 3
Vomitingd 460/5227 9 290/2310 13 74/770 10
Taking fewer fluids/milk feeds 641/5224 12 388/2302 17 107/769 14
Low energy/fatigue/lethargy 1192/5213 23 824/2301 36 229/768 30
Passing urine less often 256/5213 5 158/2306 7 42/769 6
Physical examination signs
Pallor 284/5227 5 439/2311 19 84/771 11
Nasal flaring 39/5228 1 51/2311 2 6/771 1
Grunting 25/5227 0 40/2310 2 6/771 1
Inter/subcostal recession 131/5227 3 226/2310 10 21/771 3
Wheeze 498/5228 10 624/2308 27 87/771 11
Crackles/crepitations 128/5227 2 1300/2310 56 130/770 17
Bronchial breathing 43/5225 1 210/2307 9 21/769 3
Inflamed pharynx 1250/5212 24 828/2308 36 299/771 39
Stridor 25/5226 0 11/2310 0 5/771 1
Abnormal consciousness 42/5229 1 73/2308 3 7/768 1
High respiratory rate 619/5212 12 492/2300 21 107/763 14
High temperature ≥37.8°Ce 346/5223 7 567/2307 25 116/770 15
High pulse 170/5203 3 178/2297 8 33/766 4
Capillary refill rate (≥3 seconds) 41/5216 1 18/2304 1 6/763 1
High severity score (clinician: (≥4/10) 1038/5233 20 1502/2296 65 341/768 44
Gut feeling something is wrong 273/5230 5 1265/2307 55 110/766 14
Adverse health outcomes in the 30 days post-baseline
Hospitalised  40/5236 1 21/2313 1 4/771 1
Reconsulted general practice for the same RTI  240/5104 5 91/2266 4 19/766 2 
illness with evidence of symptom deterioration
aIncludes both current and previous asthma diagnosis. bDefined as present if asthma in medical notes problem list and asthma medication issued in the previous 12 months.  
cFaster than normal. dIncluding after a cough. eHigh temperature (age-related cut-offs). IMD =  Index of Multiple Deprivation. RTI =  respiratory tract infection.
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